Close

OncoMed Pharma (OMED) Announces Presentation of Positive Ipafricept Combo Phase 1b Data at ESMO 2016

Go back to OncoMed Pharma (OMED) Announces Presentation of Positive Ipafricept Combo Phase 1b Data at ESMO 2016